UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13
AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-30959

RITA Medical Systems, Inc.
 

(Exact name of registrant as specified in its charter)

46421 Landing Parkway
Fremont, California 94538
(510) 771-0400
 

 (Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)

COMMON STOCK, $0.001 PAR VALUE PER SHARE
 

 (Title of each class of securities covered by this Form)

NONE
 

(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to
terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)(i)
[X]
Rule 12h-3(b)(1)(ii)
[   ]
 
 
Rule 12g-4(a)(1)(ii)
[   ]
Rule 12h-3(b)(2)(i)
[   ]
 
 
Rule 12g-4(a)(2)(i)
[   ]
Rule 12h-3(b)(2)(ii)
[   ]
 
 
Rule 12g-4(a)(2)(ii)
[   ]
     
 
Rule 12h-3(b)(1)(i)
[X]
Rule 15d-6
[   ]
 

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, RITA Medical Systems, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 
 
 
 
 
 
 
Date: January 29, 2007 By:   /s/ Joseph M. DeVivo
 
Joseph M. DeVivo
President and Chief Executive Officer